Progression From Presymptomatic to Clinical Type 1 Diabetes After COVID-19 Infection

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Fr1da Study Group - (Author)
  • Nadine Friedl - , Helmholtz Zentrum München - German Research Center for Environmental Health (Author)
  • Melanie Sporreiter - , Helmholtz Zentrum München - German Research Center for Environmental Health (Author)
  • Christiane Winkler - , Helmholtz Zentrum München - German Research Center for Environmental Health (Author)
  • Anja Heublein - , Helmholtz Zentrum München - German Research Center for Environmental Health (Author)
  • Florian Haupt - , Helmholtz Zentrum München - German Research Center for Environmental Health (Author)
  • Anette Gabriele Ziegler - , Helmholtz Zentrum München - German Research Center for Environmental Health (Author)
  • Ezio Bonifacio - , Chair of Preclinical stem cell therapy and diabetes (Author)

Details

Original languageEnglish
Pages (from-to)501-502
Number of pages2
JournalJAMA
Volume332
Issue number6
Publication statusPublished - 13 Aug 2024
Peer-reviewedYes

External IDs

PubMed 39008327
ORCID /0000-0002-8704-4713/work/171553158

Keywords

Sustainable Development Goals

ASJC Scopus subject areas